Citadel Advisors - LIMINAL BIOSCIENCES INC ownership

LIMINAL BIOSCIENCES INC's ticker is LMNL and the CUSIP is 53272L103. A total of 17 filers reported holding LIMINAL BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of LIMINAL BIOSCIENCES INC
ValueSharesWeighting
Q2 2022$13,000
-60.6%
26,165
-19.2%
0.00%
Q1 2022$33,000
-23.3%
32,400
-17.1%
0.00%
Q4 2021$43,000
-62.3%
39,100
-21.4%
0.00%
Q3 2021$114,000
-69.7%
49,744
-48.5%
0.00%
Q2 2021$376,000
+637.3%
96,537
+691.5%
0.00%
Q4 2020$51,000
-56.8%
12,197
+7.9%
0.00%
Q2 2020$118,00011,3010.00%
Other shareholders
LIMINAL BIOSCIENCES INC shareholders Q4 2020
NameSharesValueWeighting ↓
BREWIN DOLPHIN LTD 234$00.00%
JPMORGAN CHASE & CO 4$00.00%
Renaissance Technologies 66,400$34,0000.00%
TD Waterhouse Canada Inc. 62$420.00%
ROYAL BANK OF CANADA 18,932$10,0000.00%
UBS Group AG 7,654$4,0000.00%
IFP Advisors, Inc 131$1,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 391$00.00%
GEODE CAPITAL MANAGEMENT, LLC 22,737$11,0000.00%
View complete list of LIMINAL BIOSCIENCES INC shareholders